Our credit opportunities strategy provides senior-secured financing to breakthrough biomedical companies that are well-capitalized by top-tier institutional investors.  

We extend value-based loans secured by intellectual property or other core company assets to enable companies to grow strategically and leverage Catalio’s network and expertise while lowering their cost of capital.
learn more

Portfolio Managers

John Henry Iucker, CFA
Partner & Head of Structured Finance
Rob Snyder
Partner & Head of Credit Research
learn more


world-class founders
Transformative Technology
strong ip
experienced management
top-tier co-investors
contact us